Video Series

Dr Haumschild drives a conversation regarding CKD treatment in the presence comorbidities such as cardiovascular disease and type 2 diabetes.

The LEAP-017 trial results presented at ESMO GI 2023 are explored by Dr Marshall.

Discussion on treatment algorithms as well as the impact of sebum in acne patients.

An overview on adverse effects for topical clascoterone, minocycline, and trifarotene

The panel provides their closing thoughts as they examine the stigmas and unmet needs surrounding schizophrenia.

Future therapies for the treatment of schizophrenia are explored by a panel of key opinion leaders.

Preemptive treatment strategies for pediatric RSV are discussed by key opinion leaders.

Revolutionary advancements in monoclonal antibodies are considered for prevention of RSV.

A discussion on the benefits of combination drug therapy for adherence.

Dr Marshall discusses challenges associated with microsatellite stable metastatic colorectal cancer.

Panelists discuss the impact of pandemic-influenced process changes and shifting standards of care for the treatment of schizophrenia.

Payer considerations for evaluating treatment costs in schizophrenia care are addressed by Caroline P. Carney, MD, MSc, FAPA, FAPM, CPHQ.

The panel highlights the current standards of care and strategies for treating children with RSV.

Long-term effects of pediatric RSV diagnosis are explored.

A look at the most common medications used in patients with acne.

The panel speaks to how to treat acne for people who are pregnant and/or lactating.

An overview of data presented at ESMO GI 2023 on combined botensilimab and balstilimab therapy in heavily pretreated patients with microsatellite stable metastatic colorectal cancer.

Navigating the efficacy of schizophrenia treatment selection.

The use of cognitive behavioral therapy (CBT) in schizophrenia treatment is examined.

Medical experts discuss current obstacles facing ideal respiratory syncytial virus (RSV) treatment strategies in children.

Adam Welch, PharmD, MBA, FAPhA, leads a discussion surrounding payer considerations for RSV vaccinations in children.

A look at the psychological implications of acne in teenagers and adults.

Discussion on the economic burden of over-counter and prescription drug costs related to acne therapy.

Dr Marshall describes the impacts of microsatellite stability and instability on metastatic colorectal cancer.

Dr Carney drives a discussion surrounding optimal treatment strategies for schizophrenia.

Panelists provide insight into the standards of care for treating patients diagnosed with schizophrenia.

A panel of experts discuss future opportunities with interchangeable biosimilars from payer and provider perspectives.

Jonathan Kay, MD, and Kimberly C. Chen, DO, MSHLM, discuss clinical and financial concerns related to automatic substitution at the pharmacy for an interchangeable biosimilar from a payer perspective.